Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosis

被引:19
作者
Chehne, F
Oguogho, A
Lupattelli, G
Palumbo, B
Sinzinger, H
机构
[1] Wilhelm Auerswald Atherosclerosis Res Grp Vienna, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Nucl Med, Vienna, Austria
[3] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy
[4] Univ Perugia, Inst Nucl Med, I-06100 Perugia, Italy
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2002年 / 67卷 / 05期
关键词
D O I
10.1054/plef.2002.0438
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cigarette smoking, a key risk factor for the development of Vascular disease, is associated with an increased 8-epi-prostaglandin (PG) F-2alpha. Elevated 8-epi-PGF(2alpha) has been found in vascular tissue, blood and urine as well. We examined the influence of quitting cigarette smoking in 71 patients (38 males, 33 females; aged 32-67 a) with clinically manifested atherosclerosis and various risk factors. In addition, in eight patients with hypercholesterolemia without clinical manifestation of atherosclerosis quitting smoking was monitored as well. Twenty-six of the patients with manifested atherosclerosis and five with hypercholesterolemia restarted and the isoprostanes in plasma, serum and urine were monitored in these patients as well. Quitting cigarette smoking induces an immediate decline becoming significant after 1 or 2 weeks. Restarting smoking results in an increase in 8-epi-PGF(2alpha) reaching prevalues. within almost 1 week. These findings indicate that the in vivo oxidation injury associated with cigarette smoking quickly decreases after quitting but increases soon after restarting immediately. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 22 条
[1]  
Aghajanian AA, 1997, VASA-J VASCULAR DIS, V26, P65
[2]  
FUKUNAGA M, 1995, J CARDIOVASC PHARM, V26, pS51
[3]   VASCULAR SMOOTH-MUSCLE ACTIONS AND RECEPTOR INTERACTIONS OF 8-ISO-PROSTAGLANDIN-E2, AND E2-ISOPROSTANE [J].
FUKUNAGA, M ;
TAKAHASHI, K ;
BADR, KF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (02) :507-515
[4]   FORMATION OF PGF(2)-ISOPROSTANES DURING THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN [J].
GOPAUL, NK ;
NOUROOZZADEH, J ;
MALLET, AI ;
ANGGARD, EE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (01) :338-343
[5]  
Helmersson J, 1999, PROSTAG LEUKOTR ESS, V61, P203
[6]   Coronary artery constriction by the isoprostane 8-epi prostaglandin F-2 alpha [J].
Kromer, BM ;
Tippins, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (06) :1276-1280
[7]  
KRUPSKI WC, 1991, ANN VASC SURG, V5, P91
[8]   The influence of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets [J].
Leitinger, N ;
Blazek, I ;
Sinzinger, H .
THROMBOSIS RESEARCH, 1997, 86 (04) :337-342
[9]  
Mehrabi MR, 1999, CARDIOVASC RES, V43, P492
[10]   CIGARETTE-SMOKING AND NONFATAL MYOCARDIAL-INFARCTION - RATE RATIO IN RELATION TO AGE, SEX AND PREDISPOSING CONDITIONS [J].
MIETTINEN, OS ;
NEFF, RK ;
JICK, H .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1976, 103 (01) :30-36